Alzamend Neuro, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$2.38 | -$2.38 | -$2.38 |
| Q2 2024 | 1 | -$0.38 | -$0.38 | -$0.38 |
| Q1 2025 | 1 | -$0.77 | -$0.77 | -$0.77 |
| Q2 2025 | 1 | -$0.90 | -$0.90 | -$0.90 |
| Q3 2025 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q4 2025 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q1 2026 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q2 2026 | 1 | -$0.88 | -$0.88 | -$0.88 |
Alzamend Neuro, Inc. Earnings Date And Information
Alzamend Neuro, Inc. last posted its earnings results on Wednesday, September 11th, 2024. The company reported $-1.25 earnings per share for the quarter, topping analysts' consensus estimates of $-2.38 by $1.13. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Alzamend Neuro, Inc. has generated $-15 earnings per share over the last year ($-14.7 diluted earnings per share) and currently has a price-to-earnings ratio of -0.14. Alzamend Neuro, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 1st, 2025 based on prior year's report dates.
Alzamend Neuro, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/11/2024 | Q1 2025 | -$2.38 | -$1.25 | 1.13 | $0 | $0 |
| 07/30/2024 | Q4 2024 | -$2.75 | -$1.24 | 1.51 | $76,110 | |
| 03/25/2024 | Q3 2024 | -$0.32 | -$3.78 | -3.46 | $0 | |
| 12/15/2023 | Q2 2024 | -$0.67 | -$4.43 | -3.76 | $0 | |
| 09/13/2023 | Q1 2024 | -$0.52 | -$5.38 | -4.86 | $0 | |
| 07/27/2023 | Q4 2023 | -$0.34 | -$5.12 | -4.78 | $0 | |
| 03/15/2023 | Q3 2023 | -$0.04 | -$8.29 | -8.25 | $0 | |
| 12/12/2022 | Q2 2023 | -$0.02 | -$4.80 | -4.78 | $0 | |
| 09/13/2022 | Q1 2023 | -$0.07 | -$4.68 | -4.61 | $0 | |
| 07/19/2022 | Q4 2022 | -$0.03 | -$6.60 | -6.57 | $0 | |
| 03/15/2022 | Q3 2022 | -$0.02 | -$4.10 | -4.08 | $0 | |
| 12/13/2021 | Q2 2022 | -$0.03 | -$5.78 | -5.76 | $0 | |
| 09/13/2021 | Q1 2022 | -$4.12 | $0 | |||
| 07/29/2021 | Q4 2021 | -$2.55 | $0 | |||
| 01/30/2021 | Q3 2021 | -$2.33 | $0 | |||
| 10/30/2020 | Q2 2021 | -$2.82 | $0 | |||
| 07/30/2020 | Q1 2021 | -$2.74 | $0 | |||
| 04/29/2020 | Q4 2020 | -$2.62 | $0 | |||
| 01/30/2020 | Q3 2020 | -$2.67 | $0 | |||
| 10/30/2019 | Q2 2020 | -$1.99 | $0 |
Alzamend Neuro, Inc. Earnings: Frequently Asked Questions
-
When is Alzamend Neuro, Inc.'s earnings date?
Alzamend Neuro, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 1st, 2025 based off last year's report dates.
-
Did Alzamend Neuro, Inc. beat their earnings estimates last quarter?
In the previous quarter, Alzamend Neuro, Inc. (:ALZN) reported $-1.25 earnings per share (EPS) to beat the analysts' consensus estimate of $-2.38 by $1.13.
-
How can I listen to Alzamend Neuro, Inc.'s earnings conference call?
The conference call for Alzamend Neuro, Inc.'s latest earnings report can be listened to online.
-
How can I read Alzamend Neuro, Inc.'s conference call transcript?
The conference call transcript for Alzamend Neuro, Inc.'s latest earnings report can be read online.
-
How much profit does Alzamend Neuro, Inc. generate each year?
Alzamend Neuro, Inc. (:ALZN) has a recorded net income of $0. Alzamend Neuro, Inc. has generated $-14.72 earnings per share over the last four quarters.
-
What is Alzamend Neuro, Inc.'s price-to-earnings ratio?
Alzamend Neuro, Inc. (:ALZN) has a price-to-earnings ratio of -0.14 and price/earnings-to-growth ratio is -0.01.
